GRHL3 (Grainyhead-like 3) activators belong to a distinctive class of chemical compounds that exert their influence on gene expression by targeting and modulating the activity of the GRHL3 transcription factor. The GRHL3 protein is a critical member of the Grainyhead-like family of transcription factors, known for its pivotal role in the regulation of epithelial cell differentiation and maintenance of epithelial integrity. GRHL3 plays a fundamental role in various cellular processes, including embryonic development, wound healing, and tissue homeostasis. GRHL3 activators act as molecular switches, eliciting a cascade of events that lead to the activation of GRHL3-mediated gene transcription.
The mechanism underlying the activation of GRHL3 by these compounds involves the binding of the activators to specific regions of the GRHL3 protein, thereby inducing conformational changes that enhance its transcriptional activity. By modulating the activity of GRHL3, these activators contribute to the fine-tuning of gene expression patterns associated with epithelial cell development and function. Consequently, GRHL3 activators have garnered interest in the scientific community as valuable tools for unraveling the intricate molecular mechanisms that govern epithelial biology. Further research into the precise interactions between these activators and GRHL3 is crucial for a comprehensive understanding of their potential applications in the context of cellular development and tissue maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Activates the Wnt Signaling Pathway, potentially activating GRHL3 through its regulatory role in Wnt signaling during developmental processes. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Serves as a Notch Signaling Pathway activator, indirectly activating GRHL3 by modulating the Notch pathway, with implications for developmental regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Activates gene expression, including potential activation of GRHL3, as a Retinoic Acid (RA) that participates in developmental processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates the RAF-MEK-ERK Pathway, with downstream effects on activating GRHL3, influencing cellular processes associated with development. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Acts as a Hippo Signaling Pathway activator, potentially activating GRHL3 through its role in cellular processes related to epithelial-mesenchymal transition (EMT). | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Activates the PKC Pathway, potentially activating GRHL3 by modulating cellular processes involved in development and differentiation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates the JNK Pathway, with implications for activating GRHL3 regulation during cellular responses and developmental processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Functions as an HDAC Inhibitor, potentially activating GRHL3 through chromatin modification and gene expression regulation during development. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Activates the PI3K-Akt Pathway, with downstream effects on activating GRHL3, particularly in processes related to cell survival and proliferation during development. | ||||||